Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 9,002 Castle Biosciences, Inc. shares (Form 4)

Traded May 7, 2026 · Filed May 11, 2026

On May 7, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 9,002 Castle Biosciences, Inc. shares at an average US$22.15 for US$199K under a trading plan, leaving 2,224 shares. Filed May 11, 2026 (Form 4).

Sold
9,002 shares
Price
US$22.15 average (US$22.08 to US$22.59)
Value
US$199K
Holding after
2,224 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 7, 2026Common StockOption exercise6,214US$2.3927,693Direct
May 7, 2026Common StockSale5,308US$22.0822,385Direct
May 7, 2026Common StockSale1,159US$22.0846,336Indirect
May 7, 2026Common StockSale985US$22.0839,382Indirect
May 7, 2026Common StockSale237US$22.082,265Indirect
May 7, 2026Common StockSale906US$22.5921,479Direct
May 7, 2026Common StockSale198US$22.5946,138Indirect
May 7, 2026Common StockSale168US$22.5939,214Indirect
May 7, 2026Common StockSale41US$22.592,224Indirect

Source

View original at SEC

Related